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Classical swine fever virus (CSFV) protects cells from double-stranded (ds) RNA-mediated apoptosis and IFN-a/h induction. This
phenotype is lost when CSFV lacks Npro (DNpro CSFV). In the present study, we demonstrate that Npro counteracts dsRNA-mediated
apoptosis and IFN-a/h induction independently of other CSFV elements. For this purpose, we generated porcine SK-6 and PK-15 cell lines
constitutively expressing Npro fused to the enhanced green fluorescent protein (EGFP). The survival of the SK6-EGFP-Npro cell line after
polyinosinic polycytidylic acid [poly(IC)] treatment was comparable to that of CSFV-infected SK-6 cells and was significantly higher than
the survival of the parent cell line. In PK-15 cells, the presence of EGFP-Npro prevented the DNpro CSFV- and poly(IC)-mediated IFN-a/h
production. Importantly, Npro also inhibited IFN-a and IFN-h promoter-driven luciferase expression in human cells and blocked IFN-a/h
induction mediated by Newcastle disease virus. This establishes a novel function for Npro in counteraction of the IFN-a/h induction pathway.
D 2005 Elsevier Inc. All rights reserved.Keywords: Pestivirus; Classical swine fever virus; CSFV; Npro; Double-stranded RNA; Interferon-a/hIntroduction
Classical swine fever virus (CSFV) is the causative agent
of classical swine fever, a severe hemorrhagic disease of
pigs. CSFV together with bovine viral diarrhea virus
(BVDV) and border disease virus (BDV) belongs to the
genus Pestivirus within the Flaviviridae family. The other
members of the Flaviviridae are the genera Flavivirus and
Hepacivirus that represent important human pathogens
(vanRegenmortel et al., 2000). Pestiviruses carry an RNA0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.06.033
* Corresponding author. Fax: +41 31 848 9222.
E-mail addresses: nicolas.ruggli@ivi.admin.ch (N. Ruggli),




1 Present address: Centers for Disease Control and Prevention, NCID/
DVRD/Special Pathogens Branch, Building 15-SB Mailstop G14, Atlanta,
GA 30333, USA.genome of positive polarity that possesses a 5V untranslated
region (5VUTR), a single open reading frame (ORF) and a
3VUTR. The 5VUTR functions as an internal ribosomal entry
site (IRES) for cap-independent translation initiation of the
large ORF that is co- and posttranslationally processed into
twelve mature proteins by viral and host cell proteases (for
review, see Meyers and Thiel, 1996).
The first protein encoded by the ORF is the nonstructural
protein Npro. The only established function of Npro is its
autoproteolytical activity that allows cleavage from the
downstream nucleocapsid protein C (Rumenapf et al., 1998;
Stark et al., 1993; Wiskerchen et al., 1991). Interestingly,
Npro is unique to the pestiviruses within the Flaviviridae
family and was found to be dispensable for virus replication
in cell culture (Lai et al., 2000; Tratschin et al., 1998). The
Npro gene of the moderately virulent strain vA187-1 and the
highly virulent strain vEy-37 was deleted or replaced with
the murine ubiquitin gene that substitutes for Npro in the
generation of the authentic nucleocapsid protein. These
CSFV mutants lacking the Npro gene (DNpro CSFV)05) 265 – 276
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porcine kidney cell line SK-6 but were avirulent in pigs
(Mayer et al., 2004; Tratschin et al., 1998). Deletion of viral
genes or mutations that did not abolish virus replication in
cell culture but resulted in attenuation in the immune-
competent host led to the discovery of various mechanisms
acquired by viruses during evolution to subvert the host
defense, in particular the interferon system (for recent
reviews, see Basler and Garcia-Sastre, 2002; Goodbourn et
al., 2000; Weber et al., 2004). For the pestiviruses, it is now
well established that virus replication interferes with cellular
antiviral defense (Baigent et al., 2002; Bensaude et al.,
2004; Carrasco et al., 2004; La Rocca et al., 2005; Ruggli et
al., 2003; Schweizer and Peterhans, 2001). Our recent data
with DNpro CSFV showed that Npro was required by CSFV
to prevent double-stranded (ds) RNA-mediated apoptosis in
SK-6 cells and IFN-a/h induction in macrophages (Ruggli
et al., 2003). Furthermore, as opposed to wild-type CSFV,
DNpro CSFV induced IFN-a/h independently of exogenous
dsRNA stimulation, suggesting a role for Npro in the
counteraction of IFN-a/h induction. However, the latter
data did not exclude the requirement of other CSFV
elements in conjunction with Npro. Very recently, it was
shown that Npro of BVDV was partly responsible for
blocking interferon regulatory factor (IRF)3-dependent
transcription (Horscroft et al., 2005). Furthermore, while
this manuscript was under revision, Npro was shown to be
involved in transcriptional inhibition of IRF3 (La Rocca et
al., 2005). In addition, a recent report suggested a role of
BVDV Erns in the control of IFN-a/h induction (Iqbal et al.,
2004). In the present study, we demonstrate that Npro of
CSFV is capable of preventing polyinosinic polycytidylic
acid [poly(IC)]- and Newcastle disease virus (NDV)-
mediated IFN-a/h induction, independently of the CSFV
context. These data clearly establish a novel function for
Npro in interference with the induction of IFN-a/h.Fig. 1. Western blot analysis of EGFP-Npro and EGFP expression in stably
transformed SK-6 and PK-15 cells. SK-6 and PK-15 cells were transfected
with linearized expression plasmid and selected for G418 resistance. Single
colonies of stably transformed clones expressing EGFP-Npro fusion protein
(46 kDa) or EGFP alone (27 kDa) were picked and purified by several
rounds of end point dilution. Equivalent amounts of protein extract (5 Ag/
lane) from the cloned cell lines were separated by SDS-PAGE and analyzed
by Western blotting using mAb JL-8 directed against EGFP (A) and a rabbit
antiserum raised against Npro (B). Lane 1: molecular weight marker, lane 2:
SK6-EGFP-Npro, lane 3: SK6-EGFP, lane 4: SK-6, lane 5: PK15-EGFP-
Npro #1, lane 6: PK15-EGFP #1, lane 7: PK-15.Results
Establishment of porcine SK-6 and PK-15 cell lines
expressing the enhanced green fluorescent protein
(EGFP)-Npro fusion protein or EGFP alone
When treated with poly(IC), SK-6 cells undergo
apoptosis but do not produce any detectable IFN-a/h. In
contrast, PK-15 cells tolerate higher poly(IC) concentra-
tions in the cell culture supernatant and respond to
poly(IC) transfection with IFN-a/h production. Infection
with CSFV, as opposed to CSFV lacking the Npro gene,
prevents these cellular responses, suggesting that Npro is an
antagonist of cellular antiviral defense (Ruggli et al.,
2003). In order to study the function of Npro independently
of other CSFV elements, we established stable clonal SK-6
and PK-15 porcine kidney cell lines expressing Npro in
fusion with EGFP under the control of the humancytomegalovirus (CMV) immediate early promoter. Con-
trol cell lines expressing EGFP alone were generated in
order to exclude a non-specific effect due to expression of
a foreign protein. After repeated end point dilution, we
obtained stable SK-6 and PK-15 clones expressing the
EGFP-Npro fusion protein (SK6-EGFP-Npro, PK15-EGFP-
Npro) or EGFP alone (SK6-EGFP, PK15-EGFP). Two
independent cell clones were selected for each type of
stable transformant. As expected, a 46 kDa protein was
detected for the EGFP-Npro expressing cells with both the
anti-EGFP (Fig. 1A, lanes 2 and 5) and the rabbit anti-Npro
(Fig. 1B, lanes 2 and 5) antibodies. A 27 kDa protein was
detected for the EGFP expressing cell lines with the anti-
EGFP monoclonal antibody (mAb) (Fig. 1A, lanes 3 and
6). For the SK-6 and PK-15 clones, the expression level
of the EGFP-Npro fusion protein (46 kDa) was 10, re-
spectively 60 times lower than the EGFP (27 kDa) expres-
sion level. Six times less EGFP-Npro fusion protein was
expressed in the PK-15 clones when compared with the
SK-6 clones. The result shown in Fig. 1 for one set of
stable transformants is representative of both independent
clones.
Fig. 2. CSFV vA187-Ub-EGFP-Npro maintains the IFN-a/h antagonistic
phenotype of the parent vA187-1 virus. PK-15 cells were infected either
with vA187-Ub-EGFP-Npro, vA187-1 or with vA187-DNpro or mock-
treated as indicated and incubated for 65 h. (A) Total protein of infected
cells was extracted with hypotonic buffer, and equal amounts of protein (5
Ag/lane) were analyzed by SDS-PAGE and Western blotting using a rabbit
serum directed against Npro. Lane 1: molecular weight marker, lane 2:
vA187-Ub-EGFP-Npro, lane 3: vA187-1, lane 4: vA187-DNpro, lane 5:
mock. (B–D) Infected cells were transfected with poly(IC) or mock-
transfected (no poly(IC)) as indicated. (B) Cell culture supernatant was
collected 60 h post-transfection and analyzed for IFN-a/h bioactivity using
the Mx/CAT reporter gene assay. The detection limit of 3 U IFN-a/h per ml
is given by the lower limit of the y axis. (C–D) IFN-h mRNA induction of
infected and mock-transfected (no poly(IC)) (C) or of infected and
poly(IC)-transfected PK-15 cells (D) relative to mock-treated cells was
determined 20 h after transfection using quantitative TaqMan RT-PCR. For
IFN-a/h bioactivity, the mean values and standard deviation from 3
independent experiments are shown (B). Error bars for mRNA induction
represent minimum and maximum values of a triplicate RT-PCR (C–D).
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to prevent poly(IC)-mediated apoptosis and IFN-a/b
induction
The use of EGFP-Npro fusion for the analysis of the
IFN-a/h antagonistic function of Npro was first evaluated
in the virus context. For this purpose, the Npro gene of the
full-length cDNA clone pA187-1 was replaced by the
EGFP-Npro fusion cassette of the expression plasmid pCMV-
EGFP-Npro. Because the RNA secondary structure immedi-
ately downstream of the start codon is critical for translation
initiation of pestivirus RNA (Fletcher et al., 2002; Myers et
al., 2001), we inserted the sequence coding for the murine
ubiquitin gene between the 5VUTR and the EGFP gene. The
expression level of the EGFP-Npro fusion protein from the
cDNA-derived virus vA187-Ub-EGFP-Npro was 30 times
lower when compared with Npro expression from the vA187-
1 parent virus (Fig. 2A). However, PK-15 cells infected with
vA187-Ub-EGFP-Npro were resistant to poly(IC)-mediated
IFN-a/h induction to the same extent as vA187-1-infected
cells, whereas poly(IC) transfection induced IFN-a/h in
vA187-DNpro- and mock-infected PK-15 cells (Figs. 2B and
D, dark gray bars). The two times higher IFN-a/h expression
in mock- versus vA187-DNpro-infected cells (Fig. 2B) was
statistically significant (P < 0.001, n = 3, t test). The vA187-
Ub-EGFP-Npro- and vA187-1-mediated block of IFN-h
induction was at the level of mRNA (Figs. 2C and D). In
absence of poly(IC) transfection, vA187-DNpro induced IFN-
a/h in PK-15 cells as previously observed, whereas no IFN-
a/h expression was detected upon infection with vA187-Ub-
EGFP-Npro and vA187-1, both when bioactivity and IFN-h
mRNAwere analyzed (Figs. 2B and C, light gray bars). The
difference in the level of IFN-h mRNA upregulation
observed 20 h post-treatment for vA187-DNpro-infected
(Fig. 2C) versus poly(IC)-transfected cells (Fig. 2D) might
reflect a difference in the kinetics of induction by the two
stimuli. This was not further investigated. In SK-6 cells,
vA187-Ub-EGFP-Npro prevented poly(IC)-mediated apop-
tosis as measured in the cell survival assay (data not shown).
Taken together, these data show that CSFV expressing the
EGFP-Npro fusion protein prevents poly(IC)-mediated apop-
tosis and IFN-a/h induction to the same extent as the parent
vA187-1 virus. This validates the use of the stable cell lines
expressing Npro fused to EGFP to investigate whether Npro is
capable of conferring resistance to poly(IC)-mediated
apoptosis and to dsRNA- and virus-mediated IFN-a/h
induction, independently of other CSFV elements.
Expression of EGFP-Npro protects SK-6 cells from
dsRNA-mediated apoptosis
We have shown previously that SK-6 cells infected with
CSFV survived in the presence of higher concentrations of
poly(IC) than SK-6 cells infected with CSFV lacking the
Npro gene or mock-infected cells (Ruggli et al., 2003).
Although the mechanism of pestivirus-mediated resistanceto poly(IC) has yet to be elucidated, we analyzed whether
this phenotype could be attributed to Npro alone by using
constitutive expression of EGFP-Npro in SK-6 cells (Fig. 3).
The cell line expressing the EGFP-Npro fusion protein had a
survival rate comparable to that of CSFV vA187-1-infected
cells. The percentage of surviving SK6-EGFP-Npro cells
was significantly higher than the survival rate observed with
mock-infected cells or with cells infected with DNpro CSFV
Fig. 3. Survival assay with SK-6 cells expressing EGFP-Npro, EGFP or
E2p7. Stably transformed SK-6 clones constitutively expressing EGFP-
Npro, EGFP or E2-p7 were treated with five-fold dilutions of poly(IC) in the
cell culture medium. In parallel, SK-6 cells were either mock-infected or
infected with vA187-DNpro or vA187-1 65 h prior to poly(IC) treatment.
Cell survival was monitored 72 h later by crystal violet staining. The mean
values and standard deviation of 9 independent experiments are shown.
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proteins E2p7 of CSFV or EGFP were highly susceptible to
treatment with poly(IC). For the SK6-EGFP-Npro cells, the
degree of foreign protein expression was lower than for theFig. 4. Analysis of vA187-DNpro- and poly(IC)-mediated IFN-a/h induction in P
PK15-EGFP clones and the PK-15 parent cells were infected at a multiplicity of in
transfected with 400 ng poly(IC)/2  105 cells using FuGENE 6 transfection reage
supernatants were collected and analyzed for IFN-a/h bioactivity. For IFN-h mRNA
h induction factor of poly(IC)-transfected cells relative to mock-transfected PK-15
protein (D, lane 2) expressed in PK15-EGFP-Npro #1 cells was compared with th
vA187-1-infected PK-15 cells (D, lane 3). In panels A and B, the detection limit
bioactivity, the mean values and standard deviation of 4 (A) and 7 (B) independent
and maximum values of a triplicate RT-PCR (C).SK6-EGFP cells (Fig. 1) but was comparable to that of the
SK6-E2p7 cells (data not shown). Thus, we can conclude
that the increased survival rate to poly(IC) observed with
CSFV-infected cells can be mediated by Npro independently
of other CSFVelements and that this phenotype represents a
significant gain of function when compared with the parent
SK-6 cell line or with the SK-6 cells expressing EGFP
alone.
Npro can be complemented in trans and prevents DNpro
CSFV- and poly(IC)-mediated IFN-a/b induction in PK-15
cells
Recently, we associated the CSFV-mediated antagonism
of IFN-a/h induction with the presence of the Npro gene.
For the analysis of the effect of Npro on IFN-a/h induction,
stable clones of PK-15 cells constitutively expressing
EGFP-Npro fusion protein or EGFP alone as control were
stimulated with DNpro CSFV, poly(IC) or mock. In order to
exclude any artifact due to stable transformation of the cell
line, two independent PK-15 clones each were tested. In the
PK15-EGFP cells and the PK-15 parent cell line, DNpro
CSFV and poly(IC) induced the secretion of IFN-a/h (Figs.
4A and B). This demonstrates that constitutive expression of
a foreign protein such as EGFP does not affect the capacity
of PK-15 cells to produce IFN-a/h. In the PK15-EGFP-Npro
cell lines, DNpro CSFV did not induce any detectable IFN-a/
h bioactivity, showing that the lack of Npro in DNpro CSFV
could be complemented in trans (Fig. 4A). The amount of
EGFP-Npro protein expressed in trans (Fig. 4D, lane 2) was
comparable to the amount of Npro expressed in vA187-1-K-15 cells expressing EGFP-Npro. Two independent PK15-EGFP-Npro and
fection of 2 TCID50/cell with CSFV vA187-DN
pro, vA187-1 or mock (A) or
nt (B, C). 60 h post-infection or 40 h after poly(IC) transfection respectively,
upregulation, total RNAwas extracted 35 h post-transfection, and the IFN-
cells was determined using TaqMan RT-PCR (C). The level of EGFP-Npro
e level of Npro from an equivalent amount of total protein extracted from
of 3U IFN-a/h/ml is given by the lower limit of the y axis. For IFN-a/h
experiments are shown. Error bars for mRNA induction represent minimum
Fig. 5. Analysis of the effect of EGFP-Npro and other CSFV proteins on IFN-
a and IFN-h promoter induction in HEK293T cells. HEK293T cells were
transfected in duplicate with a mixture of plasmid phRL-SV40 and the
respective expression plasmid as indicated on the x axis and either paLuc
(IFN-a promoter) (A) or p125Luc (IFN-h promoter) (B). After 24 h, one
replica was transfectedwith 400 ng poly(IC) per 2 105 cells, and the second
replica was mock-transfected. After 18 h, the inducible firefly luciferase
activity was normalized with the constitutively expressed Renilla luciferase
activity, and the relative induction of poly(IC)-treated versus mock-treated
cells was calculated. The results are the mean of 3 (A) and 6 (B) independent
inductions with error bars representing the standard deviation.
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phenotype of vA187-1, resulting in absence of IFN-a/h
induction. Next, we asked whether Npro was capable of
blocking IFN-a/h induction independently of other CSFV
elements. For this purpose, we stimulated the stably
transformed cell lines with poly(IC) for IFN-a/h production.
After poly(IC) transfection, no IFN-a/h bioactivity was
detected in any of the Npro expressing PK-15 cell lines,
demonstrating that Npro alone was capable of blocking
dsRNA-mediated IFN-a/h induction in the absence of the
viral context. At the level of bioactivity, no significant
difference was observed between both independent clones
of each type (Fig. 4B). Quantitative reverse transcription
(RT)-PCR for IFN-h mRNA after poly(IC) stimulation
demonstrated that Npro was capable of inhibiting IFN-h
induction at the mRNA level (Fig. 4C). More sensitive than
bioactivity detection, the quantitative RT-PCR revealed a
low level of IFN-h mRNA induction in one of the PK15-
EGFP-Npro cell lines (Fig. 4C, PK15-EGFP-Npro #2). This
latter experiment was performed after multiple passages of
the PK15-EGFP-Npro clones. The IFN-h mRNA upregula-
tion in one of the two clones might reflect a loss of Npro
expression in a low percentage of cells. IFN-a/h bioactivity
in these cell culture supernatants was not analyzed. No
porcine IFN-a1 mRNA upregulation was detected in PK15-
EGFP clones or in the PK-15 cells (data not shown).
Accordingly, IFN-a/h bioactivity could not be neutralized
from the supernatant of these cells using an anti-pig IFN-a
serum (data not shown).
Npro blocks dsRNA-mediated induction of the IFN-a and
IFN-b promoter in a human cell line
The results obtained above with stably transformed PK-
15 cells demonstrate that Npro prevents IFN-h induction
independently of other CSFV elements by blocking IFN-h
mRNA upregulation. Using an independent approach, we
investigated the effect of transient expression of Npro and
various control proteins on the poly(IC)-mediated induction
of both the human IFN-a and IFN-h promoter. For this
purpose, we utilized established firefly luciferase reporter
gene assays for human IFN-a and IFN-h promoter activity
in HEK293T cells, using plasmids paLuc and p125Luc,
respectively (Yoneyama et al., 1996). The proteins Npro,
EGFP-Npro, C (Core), Erns and E2p7 of CSFV, NSs of
Bunyamwera virus (BUNV) and EGFP were transiently
expressed under the control of either the CMV promoter or
the elongation factor 1a promoter (pEAK8-derived plas-
mids). Protein expression was confirmed by in situ
immunostaining and by Western blotting (data not shown).
Two independent promoters were chosen to reduce the
possibility of artifacts due to cross talk with the IFN-a and
IFN-h promoters. The inducible firefly luciferase expression
was normalized with constitutive expression of Renilla
luciferase using phRL-SV40 (Promega) according to Mate-
rials and methods. Similar results were obtained with paLuc(Fig. 5A) and p125Luc (Fig. 5B). In the presence of the
empty expression vectors and the vectors expressing EGFP,
CSFV C and E2p7 proteins, poly(IC) transfection resulted
in a 3- to 5-fold induction of normalized firefly luciferase
expression relative to mock transfection. Interestingly, when
Erns was expressed, a slightly reduced IFN-a promoter
induction was observed whereas the IFN-h promoter
induction was not affected. With Npro alone or in fusion
with EGFP, as well as with BUNV NSs, the poly(IC)-
induced IFN-a and IFN-h promoter-driven firefly luciferase
expression was reduced to 1-fold induction relative to mock
stimulation. The inductions measured in presence of the
Npro and BUNV NSs expressing plasmids were compared
pairwise in the t test with the inductions obtained in
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or of the empty vectors. The differences were all statistically
significant (P < 0.05, n = 3 for the IFN-a promoter and n =
6 for the IFN-h promoter). These data confirm the results
obtained with the stably transformed PK-15 cells and
demonstrate that Npro of CSFV prevents dsRNA-mediated
upregulation of IFN-a/h mRNA transcription to the same
extent as BUNV NSs. This function is specific to Npro
expression since C, Erns, E2p7 and EGFP expression as well
as the empty expression vectors do not significantly impair
the activation of IFN-a/h promoters under the conditions
analyzed.
EGFP-Npro prevents NDV-mediated IFN-b induction
Awell-established property of pestiviruses is the enhance-
ment of Newcastle disease virus replication, also called END
(Inaba et al., 1963; Kumagai et al., 1958). The END
phenotype was related to suppression of IFN-a/h production
by pestiviruses (Diderholm and Dinter, 1966; Toba and
Matumoto, 1969). Therefore, we asked the question whether
Npro of CSFV was responsible for the END phenotype and
was capable of suppressing NDV-induced IFN-a/h produc-
tion in PK-15 cells independently of other CSFV elements.
For this purpose, the PK-15 clones expressing either EGFP-
Npro or EGFP alone were infected with NDVat a multiplicity
of infection of 0.1 50% tissue culture infectious dose
(TCID50)/cell. IFN-hmRNA upregulation was detected only
in PK15-EGFP clones and in the PK-15 cell line but not in the
PK15-EGFP-Npro clones (Fig. 6). IFN-a/h bioactivity in theFig. 6. Analysis of the capacity of EGFP-Npro to prevent NDV-mediated
IFN-h induction in PK-15 cells. Two independent PK15-EGFP-Npro and
PK15-EGFP clones and the PK-15 parent cells were infected at a
multiplicity of infection of 0.1 TCID50/cell with NDV or mock-infected.
At 20 h post-infection, total RNAwas extracted, and the induction factor of
IFN-h mRNA of NDV-infected cells relative to mock-infected PK-15 cells
was determined using TaqMan RT-PCR. The error bars represent minimum
and maximum values of a triplicate RT-PCR.supernatant of NDV-infected PK-15 cells could not be
measured because of the high susceptibility of the MDBK-
t2 cells to NDV that could only be partially neutralized or
inactivated. Nevertheless, these experiments show that Npro
of CSFV can suppress IFN-h induction mediated by an
unrelated virus such as NDV.Discussion
The presence of the Npro gene is a feature that distin-
guishes the pestivirus genus from the other genera of the
Flaviviridae family (for review, see Lindenbach and Rice,
2001). Autoproteolysis was the first established function of
Npro (Rumenapf et al., 1998; Stark et al., 1993;Wiskerchen et
al., 1991). Although Npro was found to be dispensable for
pestivirus replication in cell culture (Lai et al., 2000;
Tratschin et al., 1998), this gene has been maintained during
evolution, and its deletion resulted in strong attenuation of the
virus in pigs (Mayer et al., 2004). These observations led to
the hypothesis that additional functions of Npro would confer
advantage to the virus in its natural host. Recently, we
obtained strong evidence that Npro was involved in the
interference of CSFV with cellular antiviral defense mech-
anisms. The absence of Npro correlated with the loss of the
capacity of the virus to interfere with dsRNA-mediated
apoptosis and IFN-a/h induction (Ruggli et al., 2003). To
demonstrate that Npro was by itself responsible for this
interference, we established stable cell lines expressing Npro
in fusion with EGFP. This approach allowed the use of
control cell lines expressing the EGFP fusion partner alone to
exclude effects due to expression of a foreign protein.
In order to use the EGFP-Npro fusion protein to analyze
the function of Npro independently of the virus, it was
necessary to demonstrate that the fusion with EGFP did not
alter the function of Npro in the viral context. The experi-
ments shown in Fig. 2 indicate that EGFP-Npro levels far
below wild-type amounts of Npro are sufficient to mediate
complete block of poly(IC)-mediated IFN-a/h induction.
Interestingly, poly(IC) induced twice as much IFN-a/h
bioactivity in mock versus DNpro CSFV-infected cells (Fig.
2B). This difference might indicate the presence of addi-
tional CSFV elements that might modulate the IFN-a/h
induction pathways. One candidate is the Erns protein that
was shown for BVDV to specifically inactivate dsRNA-
dependent signaling events when expressed in cells or added
exogenously to the cell culture medium (Iqbal et al., 2004).
Results from our reporter assays for IFN-a and IFN-h
promoter activity in HEK293T cells however suggest that
Erns expression does not prevent IFN-a/h induction from an
intracellular dsRNA stimulus. Erns of CSFV is found in
secreted form in the supernatant of infected cells (Rumenapf
et al., 1993) and possesses RNase activity (Hulst et al.,
1994; Schneider et al., 1993). The secreted form of Erns
expressed from DNpro CSFV might account for the reduced
IFN-a/h induction by poly(IC) observed in Figs. 2B and D.
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stronger response than DNpro CSFV (Figs. 2C and D). In
PK-15 cells, the IFN-a/h bioactivity could not be blocked
with anti-pig IFN-a serum, and no IFN-a1 mRNA
upregulation could be detected (data not shown). This
indicates that the discrepancy between IFN-h mRNA and
IFN-a/h bioactivity observed in these experiments is most
probably not due to differential activation of IFN-h and
IFN-a but is rather due to the kinetics of induction.
Although we do not yet understand the mechanisms
behind the enhanced resistance of CSFV-infected SK-6 cells
to apoptosis induced by poly(IC), we demonstrate here that
the expression of EGFP-Npro independently of the virus
confers at least as good protection as infection with vA187-
1. Key players in the induction of dsRNA-mediated
apoptosis are the dsRNA-dependent protein kinase (PKR)
and the coupled 2V–5V oligoadenylate synthetase (2–5
OAS)/RNaseL system (for reviews, see Gil and Esteban,
2000; Player and Torrence, 1998; Samuel, 2001). PKR
might be directly targeted by Npro or its activation may be
inhibited indirectly through sequestration of dsRNA. These
potential mechanisms have been described for various viral
systems (for review, see Gale and Katze, 1998). Whether
Npro of CSFV has dsRNA binding activity is currently under
investigation.
Besides being an inducer of apoptosis, it is well
established that dsRNA is a potent activator of IFN-a/h
production (Goodbourn et al., 2000; Jacobs and Langland,
1996). With cytopathogenic CSFV, we found a strong
correlation between the amount of CSFV dsRNA and the
IFN-a/h induction capacity of the virus and demonstrated
that Npro modulated this induction (Bauhofer et al.,
unpublished). Transfection experiments indicated that IFN-
a/h induction was specific for in vitro synthesized CSFV
dsRNA but not for non-replicating CSFV ssRNA (Bauhofer
et al., unpublished). The cellular receptors for CSFV dsRNA
are unknown. Potential candidates are the toll-like receptors
(TLR) (for selected reviews, see Boehme and Compton,
2004; Finberg and KurtJones, 2004; Rassa and Ross, 2003)
and the helicases retinoic acid inducible gene I (RIG-I)
product (Yoneyama et al., 2004) and melanoma differ-
entiation-associated gene 5 (mda-5) product (Andrejeva et
al., 2004; Kang et al., 2002). All these pathways induce
phosphorylation of IRF3. For noncytopathogenic and
cytopathogenic BVDV, it was shown that IRF3 but not
IRF7 was phosphorylated and translocated to the nucleus in
response to virus infection, but IRF3 binding to cellular
DNA was not observed (Baigent et al., 2002, 2004). For
CSFV, La Rocca and coworkers suggested that CSFV did
not provide an effective signal for nuclear translocation of
IRF3 and that Npro inhibited expression of IRF3 at the
transcriptional level (La Rocca et al., 2005). These two
reports indicate that Npro of BVDVand CSFV may interfere
at different levels in the IFN-a/h induction pathway.
Furthermore, a recent report showed that Npro of BVDV
partly interfered with IRF3-dependent pathways (Horscroftet al., 2005). We used NSs of Bunyamwera virus as control
protein for the inhibition of IFN-a and IFN-h induction in
the transient reporter assays. This protein was shown to act
downstream of IRF3 activation by inhibiting the phosphor-
ylation of the large subunit of cellular RNA polymerase II
(Thomas et al., 2004).
The interferences observed with CSFVin the viral context,
i.e. resistance to poly(IC)-mediated apoptosis and prevention
of IFN-a/h induction after stimulation with either poly(IC) or
NDV, could be reproduced with Npro alone. Thus, Npro
certainly represents the molecular basis for the enhancement
of NDV replication by pestiviruses called END phenotype
and recognized a long time ago to be due to the virus-
mediated prevention of IFN-a/h induction (Diderholm and
Dinter, 1966; Toba and Matumoto, 1969). The observation
that Npro can act independently of CSFV does not exclude the
possibility that additional CSFV elements might exert a
similar function and act synergistically in the same or other
cell types of the host. As mentioned above, a role of Erns in
this context has been suggested for BVDV (Iqbal et al., 2004)
and needs further investigation. The block of IFN-a/h
synthesis is one of various strategies evolved by viruses to
fight the interferon system (for reviews, see Goodbourn et al.,
2000; Weber et al., 2004). It is increasingly clear that this
strategy has also evolved in pestiviruses (Baigent et al., 2002;
Bensaude et al., 2004; Carrasco et al., 2004; Ruggli et al.,
2003; Schweizer and Peterhans, 2001), and Npro is a key
player in this context (Horscroft et al., 2005; La Rocca et al.,
2005; Ruggli et al., 2003). Whether this novel function of
Npro depends on the proteinase activity or on other structural
elements of Npro or both is under current investigation. The
fact that Npro is also a functional antagonist of IFN-a/h
mRNA upregulation in human cells opens a wide range of
possibilities to analyze the pathways involved. There is no
evidence yet for major interference of pestiviruses with IFN-
a/h signaling and effector pathways (Peterhans et al., 2003;
Schweizer and Peterhans, 2001). For BVDV, it was shown
that the IFN-stimulated MxA biosynthesis was not compro-
mised in noncytopathogenic BVDV-infected cells (Baigent et
al., 2002). This is in contrast with other Flaviviridae
(Diamond, 2003) and with the closely related HCV that
interfere with IFN signaling (for review, see Macdonald and
Harris, 2004; Tan and Katze, 2001). More detailed under-
standing of the mechanisms of how Npro interferes with the
IFN-a/h induction pathways and affects virus replication in
vivo is expected to shed more light on the pathogenesis of
classical swine fever.Materials and methods
Cells and viruses
The porcine kidney cell line SK-6 (Kasza et al., 1972) was
obtained from M. Pensaert (Faculty of Veterinary Medicine,
Ghent, Belgium) and was propagated in Earle’s minimum
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serum. The porcine kidney cell line PK-15 (American Type
Culture Collection, Manassas, VA, USA) was maintained in
Dulbecco’s minimum essential medium supplemented with
5% horse serum. HEK293T cells were propagated in EMEM
supplemented with 7% fetal bovine serum (Biochrom AG,
Switzerland). TheMDBK-t2 cell line was kindly provided by
Martin D. Fray (Institute of Animal Health, Compton,
Newbury, Berkshire, UK) and maintained in EMEM supple-
mented with 7% fetal bovine serum and 10 Ag/ml blasticidin
(Invitrogen). CSFV strains vA187-1 and vA187-DNpro were
derived from the full-length cDNA clones pA187-1 (Ruggli
et al., 1996) and pA187-DNpro (Ruggli et al., 2003), re-
spectively. CSFV vA187-Ub-EGFP-Npro was rescued from
pA187-Ub-EGFP-Npro, a full-length cDNA clone in which a
cassette encoding the murine ubiquitin, the EGFP and a Gly–
Gly–Ser–Gly–Gly–Ser peptide linker, was inserted
between the 5VUTR and the Npro gene of pA187-1 (details
of the construction can be obtained on request). All cDNA-
derived viruses were rescued by electroporation of SK-6 cells
with the respective in vitro transcripts as described elsewhere
(Moser et al., 1999). NDV strain Hitchner B1 was obtained
from Lohmann AG (Cuxhaven, Germany) and passaged once
on specific pathogen-free eggs resulting in a titer of 106.5
TCID50/ml on PK-15 cells.
Plasmids
The reporter plasmids paLuc and p125Luc expressing
firefly luciferase under the control of human IFN-a and
IFN-h promoter elements respectively were a gift of Takashi
Fujita (Yoneyama et al., 1996). Plasmid phRL-SV40
(Promega) constitutively expressing Renilla luciferase was
used for internal normalization of inducible firefly lucifer-
ase. The three expression plasmids pEGFP-N1 (Clontech),
pEAK8-His derived from pEAK8 (Edge BioSystems) as
described elsewhere (Balmelli et al., 2005) and pCI-Neo
(Promega) were used to express the proteins Npro, C and
E2p7 of CSFVAlfort/187. The respective CSFV genes were
derived from the full-length cDNA clone pA187-1 (Ruggli
et al., 1996) and engineered into the expression plasmids by
standard cloning technique using PCR with PfuTurbo DNA
polymerase (Stratagene). For the construction of pCMV-
EGFP-Npro, the Npro gene was amplified with the sense
primer Bsr-GS-NproL (5V-GAGCTGTACAAGGGCG-
GAAGCGGAGGCAGCATGGAGTTGAATCATTTT-
GAACT-3V, containing the 3V end of the EGFP gene
including the restriction site BsrGI but lacking the stop
codon followed by a sequence encoding a Gly–Gly–Ser–
Gly–Gly–Ser peptide linker and by the 5V-terminal
sequence of the Npro gene) and with the antisense primer
N-st-NproR (5V-ATATAGCTGCGGCCGCTAATTAAT-
CAGCAACTGGTAACCCACAATGGA-3V, encoding the
antisense sequence of the 3V end of the Npro gene, three
stop codons and a NotI restriction site). PCR-based cloning
was also used for the construction of pEAK-Npro, pEAK-Core-6H, pCI-Ub-Core, and pCMVsigErns (details can be
obtained on request). The construct pCMVsigE2p7 was
described elsewhere (Maurer et al., 2005). Plasmid pCDNA-
BUNNSs (Weber et al., 2002) kindly provided by Friede-
mann Weber was used to express NSs of BUNV. Plasmids
were propagated in E. coli XL-1 blue (Stratagene) and
purified using the NucleoBond Plasmid DNA purification
system (Macherey-Nagel). All constructs were verified by
DNA sequencing using the Thermo Sequenase DYEnamic
direct cycle sequencing kit (Amersham Biosciences) and the
Global IR2 System and e-Seq software (LI-COR).
Selection of stably transformed cell lines
Subconfluent monolayers of SK-6 and PK-15 cells were
transfected with pCMV-EGFP-Npro or with pEGFP-N1
using FuGENE 6 transfection reagent (Roche) according
to the manufacturer’s protocol with a 6 to 1 (v/w) FuGENE
6 to DNA ratio. The plasmid DNAwas added to serum-free
EMEM containing the FuGENE 6 transfection reagent.
After 20 min of incubation at room temperature, the
transfection mixture was added directly into the complete
culture medium of the cell monolayer. After 48 h, the cell
culture medium was replaced with fresh complete medium
supplemented with 500 Ag/ml G418-Sulfate (Calbiochem-
Novabiochem Corp). Single colonies were picked and
purified by two to three rounds of end point dilution. The
purified clones were propagated under selection with 250
Ag/ml G418-sulfate.
Antibodies
For the detection of the viral protein Npro, a polyclonal
antiserum was produced in rabbits using recombinant Npro
expressed in E. coli. For this purpose, the Npro gene of
CSFV strain vA187-1 was amplified from pA187-1 using
the oligonucleotide B-NproL (5V-GCGAGCGGATCC-
GATGGAGTTGAATCATTTTGAACT-3V) containing a
BamHI site upstream of the start codon and the antisense
oligonucleotide H-st-NproR (5V-CTAGCTAAGCTTAG-
CAACTGGTAACCCACAATGGA-3V) coding for a stop
codon and a HindIII recognition site downstream of the Npro
sequence. The PCR fragment was cloned into pCR-XL-
TOPO (Invitrogen), and the DNA sequence was verified by
nucleotide sequencing as described above. The Npro gene
was then excised with BamHI and HindIII restriction
endonuclease digestion and subcloned into the BamHI and
HindIII restriction sites of the bacterial protein expression
plasmid pQE-31 (QIAGEN), in frame with a 5V-terminal
sequence encoding six histidine residues. The resulting
plasmid pQE-6H-NproA187 was then used to transform E.
coli M15 cells, and the recombinant Npro protein was
expressed by induction of a log phase culture with isopropyl
h-d-thiogalactopyranoside (IPTG) for 5 h at 37 -C. For
protein purification by nickel chelate affinity chromatog-
raphy, cells were lysed in denaturing lysis buffer (8 M Urea,
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using an AEKTA FPLC apparatus (Amersham Biosciences)
and prepacked 1-ml HiTrap chelating columns (Amersham
Biosciences), according to the manufacturer’s protocol. For
antiserum production, New Zealand white rabbits (Charles
River Laboratories) were immunized three times at 3-week
intervals with 0.5 mg purified Npro mixed 1:1 with complete
Freund’s adjuvant (Sigma) for the first immunization and
incomplete Freund’s adjuvant (Sigma) for the two booster
injections. The mAb JL-8 (BD Biosciences Clontech) was
used for the detection of EGFP by Western blotting. Alexa
Fluor 680 goat anti-mouse and anti-rabbit IgG were
obtained from Molecular Probes Inc.
Sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) and Western blotting
Cellular proteins were extracted with a hypotonic buffer
(20 mM morpholinepropanesulfonic acid, 10 mM NaCl, 1.5
mM MgCl2, 1% Triton X-100, pH 6.5). Total protein was
quantified using a bicinchoninic acid-based assay (Pierce),
and the concentration was adjusted to 1 mg/ml. Proteins
were separated by SDS-PAGE under reducing conditions
according to standard protocols (Sambrook et al., 1989).
After SDS-PAGE, gels were equilibrated for 30 min in SDS
transfer buffer (12.5 mM Tris–HCl, 125 mM glycine,
0.05% SDS, 20% methanol, pH 8.3), and the proteins were
transferred to a Trans-Blot nitrocellulose membrane (Bio-
Rad) in SDS transfer buffer at 15 V for 30 min using a
Trans-Blot SemiDry transfer device (BioRad). The mem-
branes were then washed briefly in PBS (80 mM Na2HPO4,
20 mM NaH2PO4, 100 mM NaCl, pH 7.3) and blocked for 1
h at room temperature or overnight at 4 -C with Odyssey
Blocking Reagent (LI-COR) diluted 1:1 with PBS. For
immunodetection, the membranes were incubated for 30
min at room temperature with primary and secondary
antibodies diluted in Odyssey Blocking Reagent (LI-COR)
mixed 1:1 with PBS. After each incubation period, the
membranes were washed with PBS supplemented with
0.1% Tween 20. Two final wash steps with PBS lacking
detergent were carried out prior to image acquisition and
protein quantification using the Odyssey Infrared Imaging
System (LI-COR).
Transfection of poly(IC)
For IFN-a/h induction, cells were transfected with
poly(IC) (Sigma) using FuGENE 6 transfection reagent
(Roche) according to the manufacturer’s protocol. For each
5  105 cells to be transfected, 6 Al FuGENE 6 reagent was
mixed in final volume of 100 Al serum-free EMEM prior to
addition of 1 Ag poly(IC), resulting in a 6 to 1 (v/w) ratio of
FuGENE 6 reagent to nucleic acid. After 20 min of
incubation at room temperature, the transfection mixture
was added to the cells directly into the complete culture
medium.Interferon assay
Type I IFN activity was assayed as previously described
(Ruggli et al., 2003) using an Mx/CAT reporter gene assay
developed for the quantification of bovine IFN-a/h and
kindly provided by Martin D. Fray (Institute of Animal
Health, Compton, Newbury, Berkshire, UK) (Fray et al.,
2001). This assay was validated for the detection of porcine
IFN-a/h bioactivity as described elsewhere (Ruggli et al.,
2003). Briefly, MDBK-t2 cells maintained under blasticidin
selection were seeded in 6-well plates at a density of 106
cells/well. After 24 h, samples diluted 1:5 or recombinant
porcine IFN-a standard produced in HEK293-EBNA cells
(Balmelli et al., 2005) was added to the cells in 1 ml EMEM
supplemented with 7% heat-inactivated FCS. The cells were
then incubated for 24 h prior to lysis and quantification of
chloramphenicol acetyltransferase (CAT) by CAT ELISA
(Roche). Infectious CSFV present in the samples was
neutralized by incubation for 1 h at 4 -C with polyclonal
pig anti-CSFV serum 600-88 (Ruggli et al., 1995) diluted
1:100. Virus inactivation was monitored on SK-6 cells using
immunohistochemistry with mAb HC/TC26 (Greiser-Wilke
et al., 1990). Poly(IC) was removed from the samples by
incubation at 37 -C for 1 h with a cocktail of 5 U/ml RNase
A and 200 U/ml RNase T1 (Ambion). For neutralization of
IFN-a, 250 Al of sample was incubated for 30 min on ice
with 1 Al rabbit polyclonal antibody against porcine IFN-a
(>250 neutralization U/Al as determined by the manufac-
turer, PBL Biomedical Laboratories).
Cellular RNA isolation
For IFN-h mRNA quantification, total RNA was
extracted from cells using the NucleoSpin RNA II extraction
kit (Macherey-Nagel). Typically, monolayers of 106 cells
were lysed according to the manufacturer’s protocol,
including the DNase digestion step. The purified RNA
was eluted with 60 Al RNase-free water.
Quantitative RT-PCR for porcine IFN-b mRNA
Oligonucleotides for the quantification of porcine IFN-h
mRNA by TaqMan real time RT-PCR were designed based
on the published porcine IFN-h coding sequence (GenBank
accession nos. S41178 and M86762) (Artursson et al., 1992)
using the Primer Express version 1.5 software (Applied
Biosystems). The IFN-h mRNA was amplified with sense
primer IFNbeta-L (5V-GGCTGGAATGAAACCGTCAT-3V)
and antisense primer IFNbeta-R (5V-TCCAGGATTGTCTC-
CAGGTCA-3V) in combination with the 5VFAM/3VTAMRA-
labeled TaqMan probe IFNbeta-P (5V-CCTTGTGGAACTT-
GATGGGCAGATGG-3V). For internal normalization with
GAPDH mRNA, the sense primer porcGAPDH-F (5V-
CATCACTGCCACCCAGAAGA-3V) and antisense primer
porcGAPDH-R (5V-ATGATGTTCTGGGCAGCCC-3V) were
used together with the 5VTET/3VTAMRA-labeled porc-
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designed from the porcine GAPDH nucleotide sequences
with GenBank accession nos. AF141959, AF202970 and
U82261. Real-time RT-PCR was carried out using the
TaqMan Gold RT-PCR Kit (PE Applied Biosystems). The
two-step RT-PCR consisted of a reverse transcription and of
a parallel control reaction in which the reverse transcriptase
was omitted (no RT) followed by triplicate real-time
TaqMan PCR. The 20 Al RT mixes contained RNA from
approximately 10,000 cells in 1 TaqMan Buffer A, 5.5
mM MgCl2, 500 AM of each dNTP, 2.5 AM random
hexamers, 0.8 U/Al RNasin (Promega) and 1.25 U/Al
MultiScribe reverse transcriptase and were kept for 10 min
at room temperature followed by incubation at 48 -C for 30
min and enzyme inactivation at 95 -C for 10 min. Then, 4 Al
of the RT reaction or of the no RT control reaction was
added to the PCR mix consisting of 1 TaqMan Buffer A,
4.5 mM MgCl2, 200 AM of each dNTP, 400 nM of the
respective sense and antisense primer, 100 nM of the
corresponding dual-labeled TaqMan probe and 0.02 U/Al
AmpliTaq Gold DNA polymerase in a final volume of 25 Al.
The real-time PCR was performed in a ABI PRISM 7700
Sequence Detection System (Applied Biosystems) with the
following cycling profile: 10 min at 95 -C (activation of the
AmpliTaq Gold DNA polymerase) followed by 50 cycles of
15 s at 95 -C and 60 s at 60 -C. The IFN-h mRNA induction
was calculated by subtracting the mean CT value obtained
for the RT-PCR from the CT value of the no RT control PCR
(residual DNA). The individual samples were normalized to
each other using the respective CT value for GAPDH
mRNA.
Assay for cell survival after poly(IC) treatment
Survival of SK-6 cells to poly(IC) treatment was
monitored as previously described (Ruggli et al., 2003).
Briefly, CSFV- or mock-infected SK-6 cells or stably
transformed SK-6 cell clones were treated either with serial
dilutions of poly(IC) (Sigma) or mock-treated. Cell survival
was monitored 72 h after poly(IC) treatment by crystal
violet staining. The percentage of optical density of
poly(IC)-treated versus mock-treated cultures was expressed
as percent cell survival.
Reporter gene assays
For the reporter gene assays, 2  105 HEK293T cells per
well of a 24-well plate were transfected with a mixture of
400 ng of inducible reporter plasmid paLuc or p125Luc, 2
ng of plasmid phRL-SV40 for internal normalization and 5
ng of the respective expression plasmid. DNA transfections
were performed with FuGENE 6 transfection reagent
(Roche) according to the manufacturer’s protocol as
described above using a 6 to 1 (v/w) FuGENE 6 to DNA
ratio. Cells were incubated for 24 h at 37 -C and then
transfected with 400 ng poly(IC) per well or mock-transfected as described above and incubated for additional
18 h prior to extraction and quantification of firefly and
Renilla luciferase using the Dual Luciferase Reporter assay
system (Promega) and a Lumat LB 9507 Luminometer with
two automated injectors (Berthold Technologies).
Statistical analysis
Statistical and graphical analysis was performed using
the SigmaStat and SigmaPlot software package (SPSS).Acknowledgments
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